Jj. Sheng et al., Characterization of human CYP2G genes: widespread loss-of-function mutations and genetic polymorphism, PHARMACOGEN, 10(8), 2000, pp. 667-678
CYP2G1 is an abundant, olfactory mucosa-specific cytochrome P450 enzyme act
ive in the metabolism of sex steroids and xenobiotic substrates in mammalia
n animals. Two different human CYP2G genes, CYP2GP1 and CYP2GP2, were chara
cterized in the present study. Polymorphisms in these genes were also studi
ed. CYP2GP1 contained a single nucleotide deletion in exon 2 (DeltaC) and a
2.4-kb deletion between exons 3 and 7 (Delta E4-6), whereas CYP2GP2 contai
ned a nonsense mutation in exon 1 and another in exon 3. The coding region
sequences in exons 1-3 and 7-9 of the two genes were 96.7% identical. Both
genes were localized to human chromosome 19, and Southern blot analysis of
human genomic DNA did not detect any additional copies of the CYP2G gene. T
he occurrence of these loss-of-function mutations was analysed by polymeras
e chain reaction-based genotyping in more than 200 individuals, The Delta E
4-6 deletion in CYP2GP1 was detected in 94% of subjects (either homozygous
or heterozygous), and an allele which does not contain this deletion was de
tected in 11.6% of individuals. The nonsense mutation in CYP2GP2 exon 3 was
detected in 86% of individuals (either homozygous or heterozygous); howeve
r, a potentially functional CYP2GP2 allele based on the absence of the nons
ense mutation in exon 3 was also detected in 31% of individuals. These resu
lts indicate that a functional CYP2G allele is rare in humans, Analysis of
the allelic distribution in different ethnic groups suggested that a functi
onal CYP2G allele, if present, is more likely to be found in Black and Hisp
anic subjects. Pharmacogenetics 10:667-678 (C) 2000 Lippincott Williams & W
ilkins.